News

Charging patients for HIV drugs is a barrier to treatment

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39056.466539.DB (Published 07 December 2006) Cite this as: BMJ 2006;333:1192
  1. Claire Frauenfelder
  1. 1BMJ

    Charging patients for HIV treatment is proving a barrier to treatment, health experts said last week at a conference in Geneva organised by the charity Médecins Sans Frontières.

    Charging for antiretrovirals “creates an economic problem for patients but also a public health problem for everyone else,” said Yves Souteyrand, of the World Health Organization.

    “Cost is the major barrier, over and above all others,” explained Dr Souteyrand, citing data collected in Senegal showing that removing charges increased adherence by 20%. …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe